Melanin-concentrating hormone receptor 1 antagonists: Synthesis, structure–activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
作者:Shizuo Kasai、Masahiro Kamaura、Makoto Kamata、Kazuyoshi Aso、Hitomi Ogino、Yoshihide Nakano、Kaoru Watanabe、Tomoko Kaisho、Michiko Tawada、Yasutaka Nagisa、Shiro Takekawa、Koki Kato、Nobuhiro Suzuki、Yuji Ishihara
DOI:10.1016/j.bmc.2011.09.007
日期:2011.11
Melanin-concentrating hormone receptor 1 (MCHR1) antagonists have been studied as potential agents for the treatment of obesity. Initial structure–activity relationship studies of in-house hit compound 1a and subsequent optimization studies resulted in the identification of tetrahydroisoquinoline derivative 23, 1-(2-acetyl-1,2,3,4-tetrahydroisoquinolin-7-yl)-4-[4-(4-chlorophenyl)piperidin-1-yl]butan-1-one
已经研究了黑色素浓缩激素受体1(MCHR1)拮抗剂作为治疗肥胖症的潜在药物。内部的初始结构-活性关系研究击中化合物1A和随后的优化研究导致的四氢异喹啉衍生物的识别23,1-(2-乙酰基-1,2,3,4-四氢异喹-7-基)-4- [4-(4-氯苯基)哌啶-1-基]丁-1-酮,作为有效的hMCHR1拮抗剂。hMCHR1的同源性模型表明,这些化合物在hMCHR1的结合位点与Asn294和Asp123相互作用,以增强结合亲和力。在饮食诱导的肥胖症(DIO)-F344大鼠中,口服化合物23的剂量依赖性地减少了其食物摄入。